Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Perspectives on Drug Development in Autosomal Recessive Polycystic Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN - 1 Oct 2022

Liebau Max C, Hartung Erum A, Perrone Ronald D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Development
Share to Mutation
Share to Polycystic Kidney, Autosomal Dominant
Share to Polycystic Kidney, Autosomal Recessive

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptors, Cell Surface

Source

Open in PubMed Open full text

Identifiers

PMID: 35998973
DOI: 10.2215/CJN.04870422
PMCID: PMC9528277

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Perspectives on Drug Development in Autosomal Recessive Polycystic Kidney Disease.PMID 35998973Read ↗

[Guidelines for management of autosomal recessive polycystic kidney disease].Semantic proximity Read ↗

Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights.Semantic proximity Read ↗

KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease.Semantic proximity Read ↗

Clinical practice. Autosomal dominant polycystic kidney disease.Semantic proximity Read ↗

Autosomal recessive polycystic kidney disease.Semantic proximity Read ↗

Pathogenesis of autosomal dominant polycystic kidney disease: recent developments.Semantic proximity Read ↗

[New strategy for the treatment of autosomal dominant polycystic kidney disease].Semantic proximity Read ↗

Reproductive Issues for Adults With Autosomal Dominant Polycystic Kidney DiseaseSemantic proximity Read ↗

Genetics May Predict Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease.Semantic proximity Read ↗

Pregnancy in Autosomal Dominant Polycystic Kidney DiseaseSemantic proximity Read ↗

Autosomal dominant polycystic kidney disease. Report of a Meeting of Physicians and Scientists, University College and Middlesex School of Medicine, London.Semantic proximity Read ↗

Assessing disease modifying therapies in autosomal dominant polycystic kidney diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.